ArticleFrontiers in endocrinology2025
Serum tyrosine increases all-cause mortality in an older population.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The hallmarks of protein and amino acid restriction in aging and longevity.Cell press blue · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Amino acids play crucial roles in metabolic and cardiovascular diseases, especially branched-chain and aromatic amino acids, but their association with mortality remains understudied and inconclusive. This study explored the potential correlation between serum amino acids levels (including leucine(Leu), isoleucine(Ile), valine(Val), phenylalanine(Phe), and tyrosine (Tyr) and all-cause or cardiovascular deaths in an older population. Methods: This study involved 1,238 older people selected from the Huai'an Diabetes Prevention Program aged ≥ 60 years. Baseline serum levels of five amino acids (Leu, Ile, Val, Phe and Tyr) were measured. Participants were followed for 9 years. Cox regression analysis and Fine-Gray subdistribution hazard analysis were employed to assess the association between amino acids with all-cause or cardiovascular mortality. The prognostic value of amino acids was further assessed using the C index and Net Reclassification Improvement (NRI). Results: 1 During the 9-year follow-up, 69 deaths occurred, including 32 from cardiovascular causes. Preliminary univariable analyses showed that only serum Tyr levels were associated with the risk of all-cause mortality among the five amino acids (per 1-μg/mL increase in Tyr, HR = 1.08, 95% CI = 1.01-1.17). 2 After adjustment for potential confounders, the HR and 95% CI of all-cause mortality for serum Tyr levels from the lowest to the highest quartile was 1.00 (reference), 1.31 (0.59-2.92), 2.17 (1.23-4.60), and 2.18 (1.01-4.71), respectively. 3 Compared with the traditional risk predictive model (C index = 0.773), adding serum Tyr levels increased the C index (C index = 0.787) and NRI (NRI = 0.267) for predicting all-cause mortality. Conclusions: Elevated serum tyrosine levels are independently associated with an increased risk of all-cause mortality, and may serve as a valuable biomarker for mortality risk prediction in Chinese older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.